Try a new search

Format these results:

Searched for:

person:bertif01

in-biosketch:true

Total Results:

26


Primer on Renovascular Hypertension in Children: Focus on Endovascular Intervention

Chong, Anthony T; Bertino, Frederic J; Zhu, Yuli; Lala, Shailee V; El-Ali, Alexander M; Shah, Jay H; Gill, Anne E; Patel, Premal A; Cahill, Anne Marie; Hawkins, C Matthew
Pediatric renovascular hypertension (RVHTN) results from flow-limiting disease of the renal arterial vasculature and is a potentially treatable cause of pediatric hypertension. Causes of pediatric RVHTN include idiopathic causes, fibromuscular dysplasia, neurofibromatosis, vasculitis, traumatic vascular injury, aneurysms, and aberrant renal arterial supply. Diagnostic imaging allows screening for and confirmation of pediatric RVHTN. Renal sonography with Doppler evaluation is the initial test of choice, followed by CT angiography and MR angiography. However, these modalities may not demonstrate intrarenal segmental or subsegmental branch disease. Therefore, conventional angiography maintains a significant role in diagnosis of pediatric RVHTN. Once diagnosed, pediatric RVHTN is initially treated with antihypertensive medications. Minimally invasive procedures, including angioplasty and embolization, may temporize or cure RVHTN. Surgical intervention-including renal artery reconstruction or reimplantation, aortorenal bypass grafting, or even nephrectomy-may be required for flow-limiting pathologic conditions, which often require endovascular strategies for maintenance. Renal artery stent placement is generally avoided due to limited data and risk of occlusion, although it can be considered in cases of iatrogenic dissection or severe elastic recoil refractory to angioplasty. Having appropriately sized covered stent-grafts nearby as a safety precaution is encouraged when performing these interventions. Radiologists play an invaluable role in the care of patients with pediatric RVHTN through multimodality diagnostic tools, both noninvasive and minimally invasive. The authors review medical management, diagnostic imaging, and endovascular interventions involved in caring for patients with pediatric RVHTN, to optimize diagnostic and interventional radiologist participation in multidisciplinary care with pediatric nephrologists and vascular surgeons. ©RSNA, 2025 Supplemental material is available for this article.
PMID: 40402928
ISSN: 1527-1323
CID: 5853392

Histotripsy of Pancreatic Cancer Liver Metastases: Early Outcomes and Imaging Findings

Mabud, Tarub S; Vergara, Monica; Du, Jasper; Liu, Shu; Bertino, Frederic; Taslakian, Bedros; Wolfgang, Christopher; Silk, Mikhail; Hewitt, D Brock
Patients with pancreatic ductal adenocarcinoma (PDAC) frequently present with liver metastases, which severely limit treatment options and prognosis. In other cancers, treatment of liver disease can improve outcomes and similar approaches are being explored in PDAC. Clinical data for locoregional control of pancreatic cancer liver metastases (PCLM) are limited, and histotripsy offers a new noninvasive tool for disease control. This study evaluates the preliminary safety, efficacy, and imaging findings of histotripsy in patients with PCLM.
PMID: 40445073
ISSN: 1432-2323
CID: 5854482

Protrieve Sheath embolic protection during venous thrombectomy: early experience in seventeen patients

Greenberg, Colvin; Shin, David S; Verst, Luke; Monroe, Eric J; Bertino, Frederic J; Abad-Santos, Matthew; Chick, Jeffrey Forris Beecham
PURPOSE/OBJECTIVE:The Protrieve Sheath (Inari Medical; Irvine, CA) is designed for embolic protection during venous thrombectomy. This report describes experience with its use. MATERIALS AND METHODS/METHODS:Between November 2022 and December 2023 (13 months), seventeen patients, including nine (52.9%) females and eight (47.1%) males (mean age 58.8 ± 13.3 years, range 37-81 years), underwent deep venous thrombectomy following the Protrieve Sheath placement for embolic protection. Gender, age, presenting symptoms, procedural indications, obstructed venous segments, the Protrieve Sheath access and deployment sites, thrombectomy devices utilized, need for stent reconstruction, technical success, clinical success, adverse events (the Protrieve Sheath maldeployment or clinically significant embolic events), removed thrombi analyses, and mortality were recorded. Technical success was defined as successful deployment of the Protrieve Sheath funnel central to the thrombectomy site. Clinical success was defined as improvement in presenting venous occlusive symptoms without procedure-related venous thromboembolism. RESULTS:The most common presenting symptom was extremity swelling (n = 15; 88.2%). Nine (52.9%) patients had malignant and eight (47.1%) had benign etiologies of venous obstruction. Obstructed venous segments included the inferior vena cava (IVC) and lower extremity (n = 9; 52.9%), isolated lower extremity (n = 4; 23.5%), isolated IVC (n = 2; 11.8%), thoracic central veins and superior vena cava (n = 1; 5.9%), and isolated thoracic central vein (n = 1; 5.9%). The Protrieve Sheath access sites included the right internal jugular vein (n = 15; 88.2%) for IVC and lower extremity obstructions and the right common femoral vein (n = 2; 11.8%) for thoracic central vein and superior vena cava obstructions. The Protrieve sheath funnel deployment locations included intrahepatic IVC in 13 patients (n = 13; 76.5%), suprarenal IVC in two (n = 2; 11.8%), and inferior cavoatrial junction in two (n = 2; 11.8%). Thrombectomy devices used included the ClotTriever System (Inari Medical) (n = 15; 88.2%), the InThrill Thrombectomy System (Inari Medical) (n = 4; 23.5%), the FlowTriever System (Inari Medical) (n = 2; 11.8%), the Lightning Flash 16 Aspiration System (Penumbra; Salt Lake City, UT) (n = 2; 11.8%), the Cleaner Rotational Thrombectomy System (Argon; Plano, TX) (n = 1; 5.9%), and the RevCore Thrombectomy System (Inari Medical) (n = 1; 5.9%). Ten (58.8%) patients required stent reconstruction following thrombectomy. Technical success was achieved in all patients. Clinical success was achieved in 16 (94.1%) patients. No immediate adverse events, including the Protrieve Sheath maldeployment or clinically significant embolic events, occurred. CONCLUSION/CONCLUSIONS:Use of the Protrieve Sheath during large-bore venous mechanical thrombectomy resulted in favorable technical and clinical outcomes without device-related adverse events or clinically significant thromboembolic events.
PMID: 39382712
ISSN: 2520-8934
CID: 5706102

Technical Feasibility and Clinical Efficacy of Iliac Vein Stent Placement in Adolescents and Young Adults with May-Thurner Syndrome

Bertino, Frederic J; Hawkins, C Matthew; Woods, Gary M; Shah, Jay H; Variyam, Darshan E; Patel, Kavita N; Gill, Anne E
PURPOSE/OBJECTIVE:To report technical feasibility and clinical efficacy of iliac vein stent placement in adolescent patients with May-Thurner Syndrome (MTS). MATERIALS AND METHODS/METHODS:Single-institution retrospective review of the medical record between 2014 and 2021 found 63 symptomatic patients (F = 40/63; mean age 16.1 years, 12-20 years) who underwent left common iliac vein (LCIV) stent placement for treatment of LCIV compression from an overriding right common iliac artery, or equivalent (n = 1, left IVC). 32/63 (50.7%) patients presented with non-thrombotic iliac vein lesions (NIVL). 31/63 (49.2%) patients presented with deep vein thrombosis of the lower extremity and required catheter-directed thrombolysis after stent placement (tMTS). Outcomes include technically successful stent placement with resolution of anatomic compression and symptom improvement. Stent patency was monitored with Kaplan-Meier analysis at 3, 6, 12, 24, and 36 months. Anticoagulation and antiplatelet (AC/AP) regimens were reported. RESULTS:Technical success rate was 98.4%. 74 bare-metal self-expanding stents were placed in 63 patients. Primary patency at 12, and 24-months was 93.5%, and 88.9% for the NIVL group and 84.4% and 84.4% for the tMTS group for the same period. Overall patency for the same time intervals was 100%, and 95.4% for the NIVL group and 96.9%, and 96.9% for the tMTS group. Procedural complication rate was 3.2% (2/63) with no thrombolysis-related bleeding complications. Clinical success was achieved in 30/32 (93.8%) and 29/31 (93.5%) patients with tMTS and NIVL groups, respectively. CONCLUSION/CONCLUSIONS:CIV stent placement in the setting of tMTS and NIVL is technically feasible and clinically efficacious in young patients with excellent patency rates and a favorable safety profile.
PMID: 38097769
ISSN: 1432-086x
CID: 5588912

Neonatal cholestasis: Timely triumph

Sharma, Shagun; Thomas, Kristen; Bertino, Frederic; Vittorio, Jennifer
PMCID:11018145
PMID: 38623148
ISSN: 2046-2484
CID: 5734432

Pediatric Transplant Interventions

Sharma, Pareena; Shah, Ritu; Zavaletta, Vaz; Bertino, Frederic; Sankhla, Tina; Kim, Jun Man; Leshen, Michael; Shah, Jay
The field of pediatric organ transplantation has grown significantly in recent decades, with interventional radiology (IR) playing an essential role in managing pre and post-transplant complications. Pediatric transplant patients face unique challenges compared to adults, including donor-recipient size mismatch, and complications of a growing child with changing physiology. Interventional radiologists play a major role in pediatric renal and liver transplant. IR interventions begin early in the child's pretransplant journey, with diagnostic procedures such as biopsies, angiograms, and cholangiograms. These procedures are essential for understanding the etiology of organ failure and identifying potential transplant candidates. Minimally invasive therapeutic procedures may serve as bridges to transplant and may include vascular access optimization for hemodialysis, transjugular intrahepatic portosystemic shunts (TIPS) creation, and tumor embolization or ablation. After transplant, image-guided biopsies for the surveillance of graft rejection and treatment of vascular or luminal stenoses, pseudoaneurysms, and anastomotic leaks can maintain the function and longevity of the transplant organ. Careful consideration must be given to patient size and evolving anatomy, radiation exposure, and the need for deeper sedation for pediatric patients. Despite these challenges, the integration of IR in pediatric transplant care has proven beneficial, offering minimally invasive alternatives to surgery, faster recovery times, and improved outcomes.
PMID: 38123288
ISSN: 1557-9808
CID: 5620222

Contemporary management of extracranial vascular malformations

Bertino, Frederic J; Hawkins, C Matthew
Vascular malformations are congenital vascular anomalies that originate because of disorganized angiogenesis, most commonly from spontaneous somatic genetic mutations. The modern management of vascular malformations requires a multidisciplinary team that offers patients the gamut of medical, surgical, and percutaneous treatment options with supportive care. This manuscript discusses the standard and contemporary management strategies surrounding extracranial vascular malformations and overgrowth syndromes.
PMID: 37156889
ISSN: 1432-1998
CID: 5509272

Embolic Protection During Malignant Inferior Vena Caval Thrombectomy Using the Protrieve Sheath [Letter]

Shin, David S; Abad-Santos, Matthew; Kuyumcu, Gokhan; Monroe, Eric J; Bertino, Frederic J; Jackson, Tyler; Chick, Jeffrey Forris Beecham
PMID: 36703083
ISSN: 1432-086x
CID: 5422272

Percutaneous thrombectomy of upper extremity and thoracic central veins using Inari ClotTriever System: Experience in 14 patients

Sweeney, Ashley M.; Makary, Mina S.; Greenberg, Colvin; Chick, Jeffrey Forris Beecham; Abad-Santos, Matthew; Monroe, Eric J.; Ingraham, Christopher R.; Vaidya, Sandeep; Bertino, Frederic J.; Johnson, Evan; Shin, David S.
Objective: In the present report, we have described the technical and clinical outcomes of percutaneous thrombectomy in the deep veins of the upper extremity and thorax using the ClotTriever system (Inari Medical, Irvine, CA). Methods: Fourteen patients with symptomatic deep venous occlusive disease in the upper extremity deep veins and thoracic central veins who had undergone thrombectomy using the ClotTriever system between October 2020 and January 2022 were reviewed. The technical results, adverse events, imaging follow-up data, and clinical outcomes were recorded. Results: Fourteen patients (seven men and seven women; mean age, 53.6 ± 13.3 years) constituted the study cohort. Of the 14 patients, 9 (64.3%) had had DVT due to intravascular invasion or external compression from known malignancy, 2 (14.3%) had had infected thrombi and/or vegetation due to Staphylococcus aureus refractory to intravenous antibiotic therapy, and 3 (21.4%) had had a benign etiology for thrombus formation. The presenting symptoms included upper extremity and/or facial swelling (n = 14), upper extremity pain (n = 6), fever (n = 2), and dyspnea (n = 1). Thrombectomy with the ClotTriever system was successfully completed in all 14 patients. Seven patients (50.0%) had required additional venous stent reconstruction after thrombectomy to address the underlying stenosis. No major adverse events were noted. All the patients had experienced resolution of the presenting symptoms. Conclusions: For the management of symptomatic deep venous occlusive disease of the upper extremity deep veins and thoracic central veins, thrombectomy using the ClotTriever system was feasible with excellent technical and clinical success.
SCOPUS:85148371517
ISSN: 2468-4287
CID: 5425982

Virtual interventional radiology education increases confidence in American Board of Radiology Core Exam Preparation

Shin, David S; Greenberg, Colvin H; Woerner, Andrew; Monroe, Eric J; Hage, Anthony N; Bertino, Frederic J; Chick, Jeffrey Forris Beecham
PMID: 36682181
ISSN: 1873-4499
CID: 5422262